Skip to main content

Videos

David Schwartz
Conference Coverage
10/28/2026
David A. Schwartz
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his...
10/28/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
10/23/2026
David T. Rubin, MD
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key...
10/23/2026
Advances in Inflammatory Bowel Disease Network
Nayantara Coelho-Prabhu
Conference Coverage
10/15/2026
Nayantara Coelho-Prabhu, MD
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the...
10/15/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
10/13/2026
David T. Rubin, MD
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the...
10/13/2026
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
10/11/2026
Raymond Cross, MD
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
10/11/2026
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Research Highlights
08/11/2026
Freddy Caldera, DO
Dr Caldera discusses how clinicians should approach caring for patients on advanced therapies for IBD in the face of growing outbreaks of measles—and that current guidance advises against serology to determine measles protection.
Dr Caldera discusses how clinicians should approach caring for patients on advanced therapies for IBD in the face of growing outbreaks of measles—and that current guidance advises against serology to determine measles protection.
Dr Caldera discusses how...
08/11/2026
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Expert Insights
07/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
07/19/2026
Advances in Inflammatory Bowel Disease Network
Gil Melmed
Conference Coverage
06/01/2026
Gil Y. Melmed, MD
Dr Melmed reviews the prehabilitation protocol trialed at Cedars-Sinai among patients with IBD who were preparing for surgery, which showed a definite reduction in complications among the cohort that received multidisciplinary care as well as...
Dr Melmed reviews the prehabilitation protocol trialed at Cedars-Sinai among patients with IBD who were preparing for surgery, which showed a definite reduction in complications among the cohort that received multidisciplinary care as well as...
Dr Melmed reviews the...
06/01/2026
Advances in Inflammatory Bowel Disease Network
Maria Abreu
Research Insights
05/19/2026
Maria Abreu, MD
Dr Abreu recaps the results of a late breaking abstract from Digestive Disease Week on the DUET-UC study, which tested whether a combination of two advanced therapies showed an additive or synergistic effect in patients refractory ulcerative...
Dr Abreu recaps the results of a late breaking abstract from Digestive Disease Week on the DUET-UC study, which tested whether a combination of two advanced therapies showed an additive or synergistic effect in patients refractory ulcerative...
Dr Abreu recaps the results of a...
05/19/2026
Advances in Inflammatory Bowel Disease Network